Tumor Grade Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Tumor Grade clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 2

CapTemY90 for Grade 2/3 NET Liver Metastases

Neuroendocrine TumorsNeuroendocrine Tumor Grade 2
Abramson Cancer Center at Penn Medicine70 enrolled4 locationsNCT04339036
Recruiting
Phase 2

177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

Neuroendocrine TumorsNeuroendocrine Tumor Grade 1Neuroendocrine Tumor Grade 2
University of Iowa120 enrolled1 locationNCT06395402
Recruiting
Not Applicable

Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine Tumors

Neuroendocrine Tumor Grade 1Neuroendocrine Tumor of Pancreas (Disorder)
Institut Paoli-Calmettes82 enrolled1 locationNCT04520932
Recruiting

Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)

Neuroendocrine NeoplasmNeuroendocrine TumorsNeuroendocrine Carcinoma+2 more
University of Roma La Sapienza60 enrolled1 locationNCT04464122
Recruiting
Phase 2Phase 3

Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial

Neuroendocrine NeoplasmNeuroendocrine TumorsNeuroendocrine Tumor Grade 1+1 more
The Netherlands Cancer Institute39 enrolled1 locationNCT06855095
Recruiting
Phase 2

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors

Neuroendocrine TumorsProgressionNeuroendocrine Tumor of Pancreas+4 more
AC Camargo Cancer Center100 enrolled2 locationsNCT06472388
Recruiting
Not Applicable

Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging

ClinicalDevelopment of the Virtual BiopsyTumor Grade+2 more
Poitiers University Hospital500 enrolled1 locationNCT04313140